Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
June 19, 2002

TYA Pharmaceuticals Has Recalled Various Drugs

(SafetyAlerts) - TYA Pharmaceuticals Has Recalled Various Drugs because product was labeled with incorrect expiration date.

PRODUCT
Various tablet, liquid and capsule dosage form drug products, repackaged into bottles and unit dose blister packs of varying sizes/counts, labeled with brand or generic names, strength, lot number, expiration date, National Drug Codes (NDC)and packager identified as TYA Pharmaceuticals

AGENERASE Capsules 150 mg blister packs. Recall # D-289-2;
AMITRIPTYLINE HCl Tablets 50 mg QTY 30/300. Recall # D-290-2;
*ASPIRIN ENETERIC COATED 5 GR QTY 30/300. Recall # D-291-2;
CHLORPROMAZINE Liquid 300 mg 3 mL bottles. Recall # D-292-2;
CLONIDINE HCl Tablet 0.3 mg QTY 30/300. Recall # D-293-2;
DIPHENHYDRAMINE Liquid 50 mg 20 mL bottles. Recall # D-294-2;
DIPHENHYDRAMINE Liquid 75 mg 30 mL bottles. Recall # D-295-2;
DOXEPIN Liquid 50 mg 5 mL bottles. Recall # D-296-2;
DOXEPIN Liquid 100 mg 10 mL bottles. Recall # D-297-2;
DOXEPIN Liquid 150 mg 15 mL bottles. Recall # D-298-2;
DOXEPIN Liquid 200 mg 20 mL bottles. Recall # D-299-2;
ENALAPRIL Tablets 10 mg QTY 30/400. Recall # D-300-2;
FLUPHENAZINE Liquid 5 mg 1 mL bottles. Recall # D-301-2;
FLUPHENAZINE Liquid 10 mg 2 mL bottles. Recall # D-302-2;
FLUPHENAZINE Liquid 20 mg 4 mL bottles. Recall # D-303-2;
GLYBURIDE Tablet 2.5 mg QTY 30/200. Recall # D-304-2;
HALOPERIDOL Liquid 2 mg 1 mL bottles. Recall # D-305-2;
HALOPERIDOL Liquid 5 mg 2.5 mL bottles. Recall # D-306-2;
HALOPERIDOL Liquid 10 mg 5 mL bottles. Recall # D-307-2;
HALOPERIDOL Liquid 15 mg 7.5 mL bottles. Recall # D-308-2;
HALOPERIDOL Liquid 20 mg 10 mL bottles. Recall # D-309-2;
HIVID Tablets .75 mg. Recall # D-310-2;
HYDROXYZINE HCl Liquid 25 mg 12.5 mL bottles. Recall # D-311-2;
HYDROXYZINE HCl Liquid 50 mg 25 mL bottles. Recall # D-312-2;
LITHIUM CARBONATE Capsules 300 mg QTY 30/300. Recall # D-313-2;
LITHIUM Liquid 300 mg 5 mL bottles. Recall # D-314-2;
LITHIUM Liquid 450 mg 7.5 mL bottles. Recall # D-315-2;
LITHIUM Liquid 600 mg 10 mL bottles. Recall # D-316-2;
LITHIUM Liquid 1200 mg 20 mL bottles. Recall # D-317-2;
RANITIDINE USP Tablets 150 mg QTY 30/300. Recall # D-318-2;
SUSTIVA Capsules 200 mg blister packs. Recall # D-319-2;
THIORIDAZINE Liquid 75 mg .75 mL bottles. Recall # D-320-2;
THIORIDAZINE Liquid 100 mg 1 mL bottles. Recall # D-321-2;
THIORIDAZINE Liquid 200 mg 2 mL bottles. Recall # D-322-2;
TRIAMTERENE HCTZ Capsules 50/25 mg QTY 30/300. Recall # D-323-
2;
VALPROIC ACID Liquid 500 mg 10 mL bottles. Recall # D-324-2;
VALPROIC ACID Liquid 1000 mg 20 mL bottles. Recall # D-325-2;
ZERIT Capsules 30 mg blister packs. Recall # D-326-2;
ZERIT Capsules 40 mg blister packs. Recall # D-327-2;
ZITHROMAX Tablets 600 mg blister packs. Recall # D-328-2;
CHLORPROMAZINE Liquid 100 mg 1 mL bottles. Recall # D-333-2
*Enteric is misspelled on product label.
CODE
AGENERASE Capsules 150 mg blister packs--------Lot# 00382C
AMITRIPTYLINE HCl Tablets 50 mg QTY 30/300-----Lot# 001081A
ASPIRIN ENETERIC COATED 5 GR QTY 30/300--------Lot# 1539
CHLORPROMAZINE Liquid 300 mg 3 mL bottles------Lot# 156294A
CLONIDINE HCl Tablet 0.3 mg QTY 30/300---------Lot# 1J2840
DIPHENHYDRAMINE Liquid 50 mg 20 mL bottles-----Lot# 2607A
DIPHENHYDRAMINE Liquid 75 mg 30 mL bottles-----Lot# 2607A
DOXEPIN Liquid 50 mg 5 mL bottles--------------Lot# 2678A
DOXEPIN Liquid 100 mg 10 mL bottles------------Lot# 2678A
DOXEPIN Liquid 150 mg 15 mL bottles------------Lot# 2678A
DOXEPIN Liquid 200 mg 20 mL bottles------------Lot# 2678A
ENALAPRIL Tablets 10 mg QTY 30/400-------------Lot# CHO0987,
1170205
FLUPHENAZINE Liquid 5 mg 1 mL bottles----------Lot# MFC06
FLUPHENAZINE Liquid 10 mg 2 mL bottles---------Lot# MFC06
FLUPHENAZINE Liquid 20 mg 4 mL bottles---------Lot# MFC06
GLYBURIDE Tablet 2.5 mg QTY 30/200-------------Lot# 124884A
HALOPERIDOL Liquid 2 mg 1 mL bottles-----------Lot# 2505A, 2505D
HALOPERIDOL Liquid 5 mg 2.5 mL bottles---------Lot# 2505A, 2505D
HALOPERIDOL Liquid 10 mg 5 mL bottles----------Lot# 2505A, 2505D
HALOPERIDOL Liquid 15 mg 7.5 mL bottles--------Lot# 2505A, 2505D
HALOPERIDOL Liquid 20 mg 10 mL bottles---------Lot# 2505A, 2505D
HIVID .75mg-----------------------------------Lot# 47117A,
40558A
HYDROXYZINE HCl Liquid 25 mg 12.5 mL bottles---Lot# 24303C
HYDROXYZINE HCl Liquid 50 mg 25 mL bottles-----Lot# 24303C
LITHIUM CARBONATE Capsules 300 mg QTY 30/300---Lot# 111077A
LITHIUM CITRATE Liquid 300 mg 5 mL bottles-----Lot# 158273A,
158274A
LITHIUM CITRATE Liquid 450 mg 7.5 mL bottles---Lot# 158273A,
158274A
LITHIUM CITRATE Liquid 600 mg 10 mL bottles----Lot# 158273A,
158274A
LITHIUM CITRATE Liquid 1200 mg 20 mL bottles---Lot# 158273A,
158274A
RANITIDINE USP Tablets 150 mg QTY 30/300-------Lot# 00382C
SUSTIVA Capsules 200 mg blister packs----------Lot# EPK347A,
EPK372A, EPK373A
THIORIDAZINE Liquid 75 mg .75 mL bottles-------Lot# 156303A
THIORIDAZINE Liquid 100 mg 1 mL bottles--------Lot# 156303A
THIORIDAZINE Liquid 200 mg 2 mL bottles--------Lot# 156303A
TRIAMTERENE HCTZ Capsules 50/25 mg QTY 30/300--Lot# 101901A
VALPROIC ACID Liquid 500 mg 10 mL bottles------Lot# 14010
VALPROIC ACID Liquid 1000 mg 20 mL bottles-----Lot# 14010
ZERIT Capsules 30 mg blister packs-------------Lot# 1C50244
ZERIT Capsules 40 mg blister packs-------------Lot# 1G52495
ZITHROMAX Tablets 600 mg blister packs---------Lot# 009K01E
CHLORPROMAZINE Liquid 100 mg 1mL bottles-------Lot# 156294A.

RECALLING FIRM/MANUFACTURER
TYA Pharmaceuticals, Tallahassee, FL, by telephone and letter on February 27, 2002. Firm initiated recall is ongoing.

REASON
Labeled with incorrect expiration date.

VOLUME OF PRODUCT IN COMMERCE
277,750 doses.

DISTRIBUTION
TX and FL.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.